Immunohistochemical analysis of salivary gland tumors: Application for surgical pathology practice

Acta Histochemica et Cytochemica

Volumn 45, Issue 5, 2012, Pages 269-282

  Nagao, Toshitaka ^a   Sato, Eiichi ^a   Inoue, Rie ^a   Oshiro, Hisashi ^a   Takahashi, Reisuke H ^a   Nagai, Takeshi ^a   Yoshida, Maki ^a   Suzuki, Fumie ^a   Obikane, Hiyo ^a   Yamashina, Mitsumasa ^a   Matsubayashi, Jun ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Diagnosis; Immunohistochemistry; Pathology; Salivary gland tumor

Indexed keywords

EID: 84868361214     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.12019     Document Type: Review

References (82)

1. Abbondanzo, S. L. (2001) Extranodal marginal-zone B-cell lym-phoma of the salivary gland. Ann. Diagn. Pathol. 5; 246-254.
2. Andreadis, D., Epivatianos, A., Poulopoulos, A., Nomikos, A., Papazoglou, G., Antoniades, D. and Barbatis, C. (2006) Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol. 42; 57-65.
3. Bahrami, A., Dalton, J. D., Shivakumar, B. and Krane, J. F. (2012) PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases. Head Neck Pathol. in press.
4. Barnes, L., Eveson, J. W., Reichart, P. and Sidransky, D. (ed.). (2005) World Health Organization Classification of Tumors: Pathology and Genetics of the Head and Neck Tumours, IARC Press, Lyon, France.
5. Bell, D., Roberts, D., Karpowicz, M., Hanna, E. Y., Weber, R. S. and El-Naggar, A. K. (2011) Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol. Ther. 12; 569-573.
6. Ben-Izhak, O., Kaplan-Cohen, V., Ilan, N., Gan, S., Vlodavsky, I. and Nagler, R. (2006) Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival. Neoplasia 8; 879-884.
7. Ben-Izhak, O., Akrish, S., Gan, S. and Nagler, R. M. (2009) Skp2 and salivary cancer. Cancer Biol. Ther. 8; 153-158.
8. Brill, L. B., Kanner, W. A., Fehr, A., Andrén, Y., Moskaluk, C. A., Löning, T., Stenman, G. and Frierson, H. F. (2011) Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod. Pathol. 24; 1169-1176.
9. Chênevert, J., Duvvuri, U., Chiosea, S., Dacic, S., Cieply, K., Kim, J., Shiwarski, D. and Seethala, R. R. (2012) DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod. Pathol. in press.
10. Cheuk, W. and Chan, J. K. (2007) Advances in salivary gland pathology. Histopathology 51; 1-20.
11. Chhieng, D. C. and Paulino, A. F. (2002) Basaloid tumors of the salivary glands. Ann. Diagn. Pathol. 6; 364-372.
12. Childers, E. L., Ellis, G. L. and Auclair, P. L. (1996) An immuno-histochemical analysis of anti-amylase antibody reactivity in acinic cell adenocarcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 81; 691-694.
13. Curran, A. E., White, D. K., Damm, D. D. and Murrah, V. A. (2001) Polymorphous low-grade adenocarcinoma versus pleo-morphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91; 194-199.
14. Curran, A. E., Allen, C. M., Beck, F. M., Damm, D. D. and Murrah, V. A. (2007) Distinctive pattern of glial fibrillary acidic protein immunoreactivity useful in distinguishing fragmented pleomorphic adenoma, canalicular adenoma and polymorphous low grade adenocarcinoma of minor salivary glands. Head Neck Pathol. 1; 27-32.
15. Dardick, I., Bradley, G., Lee, L. and Leong, I. (2006) Atlas of Salivary Gland Tumor Oral & Surgical Pathology, Pathology Images Inc, Ottawa.
16. DeRoche, T. C., Hoschar, A. P. and Hunt, J. L. (2008) Immuno-histochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas. Arch. Pathol. Lab. Med. 132; 1907-1911.
17. Di Palma, S., Skálová, A., Vanìèek, T., Simpson, R. H., Stárek, I. and Leivo, I. (2005) Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/ neu and MIB1 immunohistochemistry. Histopathology 46; 144-152.
18. Ellis, G. L. (1998) Clear cell neoplasms in salivary glands: clearly a diagnostic challenge. Ann. Diagn. Pathol. 2; 61-78.
19. Ellis, G. L. and Auclair, P. L. (2008) Tumors of the Salivary Glands. Fascicle 9, 4th Series, Atlas of Tumor Pathology, Armed Forces Institute of Pathology, Washigton DC.
20. Ettl, T., Schwarz, S., Kleinsasser, N., Hartmann, A., Reichert, T. E. and Driemel, O. (2008) Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 53; 567-577.
21. Ettl, T., Baader, K., Stiegler, C., Müller, M., Agaimy, A., Zenk, J., Kühnel, T., Gosau, M., Zeitler, K., Schwarz, S. and Brockhoff, G. (2012) Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. Br. J. Cancer 106; 719-726.
22. Ettl, T., Schwarz-Furlan, S., Haubner, F., Müller, S., Zenk, J., Gosau, M., Reichert, T. E. and Zeitler, K. (2012) The PI3K/AKT/ mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation. Oral Oncol. in press.
23. Ettl, T., Stiegler, C., Zeitler, K., Agaimy, A., Zenk, J., Reichert, T. E., Gosau, M., Kühnel, T., Brockhoff, G. and Schwarz, S. (2012) EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. Hum. Pathol. in press.
24. Eveson, J. W. and Nagao, T. (2009) Chapter 10. Diseases of the salivary glands. In "Surgical Pathology of the Head and Neck", ed. by L. Barnes, Informa Healthcare, pp. 475-648.
25. Fan, C. Y., Wang, J. and Barnes, E. L. (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am. J. Surg. Pathol. 24; 579-586.
26. Franchi, A., Gallo, O., Bocciolini, C., Franchi, L., Paglierani, M. and Santucci, M. (1999) Reduced E-cadherin expression correlates with unfavorable prognosis in adenoid cystic carcinoma of salivary glands of the oral cavity. Am. J. Clin. Pathol. 111; 43-50.
27. Furuse, C., Sousa, S. O., Nunes, F. D., Magalhães, M. H. and Araújo, V. C. (2005) Myoepithelial cell markers in salivary gland neoplasms. Int. J. Surg. Pathol. 13; 57-65.
28. Handra-Luca, A., Lamas, G., Bertrand, J. C. and Fouret, P. (2005) MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am. J. Surg. Pathol. 29; 881-889.
29. Hashimoto, K., Yamamoto, H., Shiratsuchi, H., Nakashima, T., Tamiya, S., Higaki, Y., Komune, S., Tsuneyoshi, M. and Oda, Y. (2011) S100P expression in ductal type of carcinoma ex pleo-morphic adenoma. Am. J. Surg. Pathol. 35; 346-355.
30. Hata, M., Amano, I., Tsuruga, E., Kojima, H. and Sawa, Y. (2010) Immunoelectron microscopic study of podoplanin localization in mouse salivary gland myoepithelium. Acta Histochem. Cytochem. 43; 77-82.
31. He, J. F., Ge, M. H., Zhu, X., Chen, C., Tan, Z., Li, Y. N. and Gu, Z. Y. (2008) Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis. Cancer Sci. 99; 1334-1340.
32. Ianez, R. F., Buim, M. E., Coutinho-Camillo, C. M., Schultz, R., Soares, F. A. and Lourenço, S. V. (2010) Human salivary gland morphogenesis: myoepithelial cell maturation assessed by immu-nohistochemical markers. Histopathology 57; 410-417.
33. Ihrler, S., Blasenbreu-Vogt, S., Sendelhofert, A., Lang, S., Zietz, C. and Löhrs, U. (2002) Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol. Res. Pract. 198; 777-783.
34. Jaehne, M., Roeser, K., Jaekel, T., Schepers, J. D., Albert, N. and Löning, T. (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103; 2526-2533.
35. Jaso, J., Chen, L., Li, S., Lin, P., Chen, W., Miranda, R. N., Konoplev, S., Medeiros, L. J. and Yin, C. C. (2012) CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. in press.
36. Jaspers, H. C., Verbist, B. M., Schoffelen, R., Mattijssen, V., Slootweg, P. J., van der Graaf, W. T. and van Herpen, C. M. (2011) Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J. Clin. Oncol. 29; e473-476.
37. Jia, L., Esguerra, R. L., Tang, X., Yin, H., Sakamoto, K., Okada, N. and Takagi, M. (2004) Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol. Int. 54; 217-223.
38. Kane, S. V. and Bagwan, I. N. (2010) Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 51 cases in a tertiary cancer center. Arch. Otolaryngol. Head Neck Surg. 136; 702-712.
39. Kanner, W. A., Galgano, M. T. and Atkins, K. A. (2010) Podo-planin expression in basal and myoepithelial cells: utility and potential pitfalls. Appl. Immunohistochem. Mol. Morphol. 18; 226-230.
40. Kapadia, S. B. and Barnes, L. (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod. Pathol. 11; 1033-1038.
41. Langman, G., Andrews, C. L. and Weissferdt, A. (2011) WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium. Mod. Pathol. 24; 168-174.
42. Maruya, S., Shirasaki, T., Nagaki, T., Kakehata, S., Kurotaki, H., Mizukami, H. and Shinkawa, H. (2009) Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications. BMC Cancer 9; 72.
43. Matsuyama, A., Hisaoka, M., Nagao, Y. and Hashimoto, H. (2011) Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch. 458; 583-592.
44. McHugh, J. B., Hoschar, A. P., Dvorakova, M., Parwani, A. V., Barnes, E. L. and Seethala, R. R. (2007) P63 immunohistochem-istry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 1; 123-131.
45. Michal, M., Skálová, A., Simpson, R. H., Rychterová, V. and Leivo, I. (1996) Clear cell malignant myoepithelioma of the salivary glands. Histopathology 28; 309-315.
46. Mori, Y., Tsukinoki, K., Yasuda, M., Miyazawa, M., Kaneko, A. and Watanabe, Y. (2007) Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors. Oral Oncol. 43; 563-569.
47. Nagao, T., Ishida, Y., Sugano, I., Tajima, Y., Matsuzaki, O., Hino, T., Konno, A., Kondo, Y. and Nagao, K. (1996) Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion. Cancer 78; 695-703.
48. Nagao, T., Sugano, I., Ishida, Y., Tajima, Y., Matsuzaki, O., Konno, A., Kondo, Y. and Nagao, K. (1998) Salivary gland malignant myoepithelioma: a clinicopathologic and immuno-histochemical study of ten cases. Cancer 83; 1292-1299.
49. Nagao, T., Sugano, I., Ishida, Y., Hasegawa, M., Matsuzaki, O., Konno, A., Kondo, Y. and Nagao, K. (1998) Basal cell adeno-carcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer 82; 439-447.
50. Nagao, T., Gaffey, T. A., Kay, P. A., Minato, H., Serizawa, H. and Lewis, J. E. (2004) Polymorphous low-grade adenocarcinoma of the major salivary glands: report of three cases in an unusual location. Histopathology 44; 164-171.
51. Nagao, T., Gaffey, T. A., Olsen, K. D., Serizawa, H. and Lewis, J. E. (2004) Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immu-noreactivity and clinical outcome. Am. J. Surg. Pathol. 28; 762-770.
52. Nagler, R. M., Ben-Izhak, O., Ostrovsky, D., Golz, A. and Hershko, D. D. (2009) The expression and prognostic significance of Cks1 in salivary cancer. Cancer Invest. 27; 512-520.
53. Nakajima, Y., Kishimoto, T., Nagai, Y., Yamada, M., Iida, Y., Okamoto, Y., Ishida, Y., Nakatani, Y. and Ichinose, M. (2009) Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland. Pathology 41; 634-639.
54. Nasser, S. M., Faquin, W. C. and Dayal, Y. (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am. J. Clin. Pathol. 119; 801-806.
55. Navarro Rde, L., Martins, M. T. and de Araújo, V. C. (2004) Maspin expression in normal and neoplastic salivary gland. J. Oral Pathol. Med. 33; 435-440.
56. Neves Cde, O., Soares, A. B., Costa, A. F., de Araujo, V. C., Furuse, C., Juliano, P. B. and Altemani, A. (2010) CD10 (neutral endopeptidase) expression in myoepithelial cells of salivary neoplasms. Appl. Immunohistochem. Mol. Morphol. 18; 172-178.
57. Okabe, M., Inagaki, H., Murase, T., Inoue, M., Nagai, N. and Eimoto, T. (2001) Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Mod. Pathol. 14; 1008-1014.
58. Pires, F. R., Azevedo, R. S., Ficarra, G., Cardoso, A. S., Carlos, R., Kowalski, L. P. and de Almeida, O. P. (2010) Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohisto-chemical study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109; e22-27.
59. Prasad, M. L., Barbacioru, C. C., Rawal, Y. B., Husein, O. and Wen, P. (2008) Hierarchical cluster analysis of myoepithelial/ basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod. Pathol. 21; 105-114.
60. Ramer, N., Wu, H., Sabo, E., Ramer, Y., Emanuel, P., Orta, L. and Burstein, D. E. (2010) Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer 116; 77-83.
61. Russo, G., Zamparelli, A., Howard, C. M., Minimo, C., Bellan, C., Carillo, G., Califano, L., Leoncini, L., Giordano, A. and Claudio, P. P. (2005) Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin. Cancer Res. 11; 3265-3273.
62. Savera, A. T., Sloman, A., Huvos, A. G. and Klimstra, D. S. (2000) Myoepithelial carcinoma of the salivary glands: a clinico-pathologic study of 25 patients. Am. J. Surg. Pathol. 24; 761-774.
63. Savera, A. T. and Zarbo, R. J. (2004) Defining the role of myo-epithelium in salivary gland neoplasia. Adv. Anat. Pathol. 11; 69-85.
64. Schwarz, S., Ettl, T., Kleinsasser, N., Hartmann, A., Reichert, T. E. and Driemel, O. (2008) Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Oral Oncol. 44; 563-570.
65. Seethala, R. R. (2011) Histologic grading and prognostic biomar-kers in salivary gland carcinomas. Adv. Anat. Pathol. 18; 29-45.
66. Shah, S. S., Chandan, V. S., Wilbur, D. C. and Khurana, K. K. (2007)Glial fibrillary acidic protein and CD57 immunolocalization in cell block preparations is a useful adjunct in the diagnosis of pleomorphic adenoma. Arch. Pathol. Lab. Med. 131; 1373-1377.
67. Shinozaki, A., Nagao, T., Endo, H., Kato, N., Hirokawa, M., Mizobuchi, K., Komatsu, M., Igarashi, T., Yokoyama, M., Masuda, S., Sano, K., Izumi, M., Fukayama, M. and Mukai, K. (2008)Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical anal ysis of 6 cases of a new histologic variant. Am. J. Surg. Pathol. 32; 913-923.
68. Shintaku, M. and Honda, T. (1997) Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohisto-chemistry. Histopathology 31; 408-411.
69. Skalova, A. and Leivo, I. (1996) Cell proliferation in salivary gland tumors. Gen. Diagn. Pathol. 142; 7-16.
70. Skálová, A., Simpson, R. H., Lehtonen, H. and Leivo, I. (1997) Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol. Res. Pract. 193; 695-703.
71. Stenner, M. and Klussmann, J. P. (2009) Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur. Arch. Otorhinolaryngol. 266; 333-341.
72. Stenner, M., Demgensky, A., Molls, C., Hardt, A., Luers, J. C., Grosheva, M., Huebbers, C. U. and Klussmann, J. P. (2011) Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypes. Eur. J. Cancer 47; 1013-1020.
73. Takata, T., Kudo, Y., Zhao, M., Ogawa, I., Miyauchi, M., Sato, S., Cheng, J. and Nikai, H. (1999) Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis. Cancer 86; 928-935.
74. Tameno, H., Chano, T., Ikebuchi, K., Ochi, Y., Arai, A., Kishimoto, M., Shimada, T., Hisa, Y. and Okabe, H. (2012) Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers. Head Neck 34; 674-680.
75. Völker, H. U., Scheich, M., Berndt, A., Haubitz, I., Metzger, A., Müller-Hermelink, H. K., Kämmerer, U. and Schmidt, M. (2009) Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses. Diagn. Pathol. 4; 18.
76. Wang, B., Brandwein, M., Gordon, R., Robinson, R., Urken, M. and Zarbo, R. J. (2002) Primary salivary gland clear cell tu-mors-a diagnostic approach: A clinicopathologic and immuno-histochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelial-myoepithelial carcinoma. Arch. Pathol. Lab. Med. 126; 676-685.
77. Wee, D. T., Thomas, A. A. and Bradley, P. J. (2012) Salivary duct carcinoma: what is already known, and can we improve survival? J. Laryngol. Otol. 12; 1-6.
78. West, R. B., Kong, C., Clarke, N., Gilks, T., Lipsick, J. S., Cao, H., Kwok, S., Montgomery, K. D., Varma, S. and Le, Q. T. (2011) MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am. J. Surg. Pathol. 35; 92-99.
79. Williams, M. D., Roberts, D., Blumenschein, G. R., Temam, S., Kies, M. S., Rosenthal, D. I., Weber, R. S. and El-Naggar, A. K. (2007) Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am. J. Surg. Pathol. 31; 1645-1652.
80. Yamazaki, M., Fujii, S., Murata, Y., Hayashi, R. and Ochiai, A. (2010) High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas. Histopathology 56; 883-892.
81. Zarbo, R. J. (2002) Salivary gland neoplasia: a review for the practicing pathologist. Mod. Pathol. 15; 298-323.
82. Zhang, J., Peng, B. and Chen, X. (2005) Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular en-dothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outco me. Clin. Cancer Res. 11; 7334-7343.